Mouse models

Mouse in laboratory
#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations #Whitepaper

Whitepaper: Ensure accurate dose prediction for clinical trials

Accurate dose prediction for clinical trials is essential to ensure patient safety and trial success. This new whitepaper from the Jackson Laboratory discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models. In this whitepaper you will learn about: The significance… Read More

#News

#Clinical trials #Drug toxicity #Mouse models #Pharmacology #Preclinical investigations

Discover evidence-based, first-in-human dose selection

This whitepaper discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models and emphasises the importance of accurate dose prediction to ensure patient safety and trial success. In this whitepaper you will learn about: The significance of selecting appropriate starting doses in clinical… Read More

#Resources

Lab mouse
#Animal models #Drug discovery #Mouse models #Taconic

More efficient mouse model generation through informed founder selection

This paid-for advertorial by Taconic appeared in DDW Volume 24 – Issue 3, Summer 2023 Overcoming challenges in model generation Genetically engineered mouse models are essential tools for biomedical research. Yet when seeking to obtain an existing model, researchers often encounter obstacles related to intellectual property, availability, or licensing. As a… Read More

#Exclusive Content

Lab mouse
#APAC #Contract Research Organisations (CROs) #Mouse models #Partnership #Preclina #TransCure bioServices

Partnership aims to boost preclinical services in APAC region

Humanised mouse model CRO TransCure bioServices and South Korean CRO Preclina have agreed a partnership to improve preclinical development services in the APAC region. Drug developers in APAC have typically faced many challenges when it comes to preclinical development, from limited access to animal model providers… Read More

#News

#Animal models #Cancer immunotherapy #Cell therapy #Covid-19 #Humanised Immune System (HIS) #Immunotherapy #Monoclonal antibodies #Mouse models #Oncology #Regulatory

Podcast: Immunotherapy, avelumab and the immunocompromised

This is the latest episode of the free DDW narrated podcast, “Immunotherapy, avelumab and protecting the immunocompromised”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Mice with humanised immune systems advance cell-based immunotherapy”, “… Read More

#News

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations #TransCure bioServices

Unlock the full potential of your preclinical oncology studies

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. This new Guide from TransCure bioServices explores how humanized mouse models can help accelerate the successful development… Read More

#News

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations

Unlock the full potential of your preclinical oncology studies with a humanized mouse model

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. Our Guide explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments… Read More

#Intelligence #Resources

Back pain
#Chemical engineering #Mouse models #Painkillers #Preclinical investigations

Researchers modify anti-nausea drug to treat pain

Altering the chemical properties of an anti-nausea drug enables it to enter an interior compartment of the cell and provide long-lasting pain relief, according to a new study led by researchers at NYU College of Dentistry’s Pain Research Center. The study, published in the Proceedings of… Read More

#News

#Animal models #Animal testing #Assays #Drug development #Drug discovery #Mouse models

Accelerating NDA filing through faster carcinogenicity assessment

Dr Megan MacBride and Dr Caroline Horizny Mitchell, Taconic, examine recent changes to animal testing in drug design. Drug discovery and development is an arduous process that can cost upwards of $2.6 billion and take over 10 years. While the discovery phase – which includes target discovery, target validation, lead… Read More

#Exclusive Content

Cancer immunotherapy
#Animal models #Cancer research #Immunotherapy #Mouse models #Taconic

Immunotherapy advancements with humanised immune system mouse models

This article is sponsored by Taconic. The cancer therapeutic landscape changed dramatically with the introduction of immune checkpoint inhibitors (ICIs) that target T cells and leverage a patient’s immune system. Success in targeting T cells as immunotherapy has prompted investigators to explore whether other immune cell… Read More

#News

Neurons in a brain with Alzheimer's disease
#Alzheimer's #Brain #Gut microbiome #Mouse models #Neurology #Neuroscience

Mouse study findings suggest new approach to treating Alzheimer’s 

Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.  Context   Researchers at Washington University School of Medicine in St Louis showed that… Read More

#News

Cancer cells
#Brain disease #Cancer research #Cell and gene therapy #CRISPR #CRISPR-Cas9 #Gene editing #Mouse models #Neuroscience #Oncology

Scientists turn cancer cells into anticancer agents

Harvard investigators have developed a new cell therapy approach to eliminate established tumours and induce long-term immunity.   In this early research, Khalid Shah, Professor of Neurosurgery at Harvard Medical School and Brigham and Women’s Hospital, and colleagues tested the vaccine in an advanced mouse model of brain… Read More

#Cancer Research #News #Trending News

Laboratory mouse
#Genetics / genomics #Japan #Mouse models #Muscles #Proteins

Study could pave way for new muscle atrophy treatments

Researchers have identified the genetic links between muscle atrophy and two types of myosin, paving the way for a new disease model for scientific research and potential new treatments.  The synergistic action of the muscle proteins myosin and actin enables skeletal muscle movements. The skeletal muscle myosin… Read More

#News

CAR-T therapy
#Autoimmune disease #Cancer #CAR-T #Immunotherapy #Mouse models

CAR-T therapy successfully used to treat autoimmune disease

CAR-T therapy can be used to eliminate unwanted cells that cause autoimmunity, according to the results of a new study in mice with an autoimmune disease similar to multiple sclerosis (MS).  CAR-T, which uses genetically altered immune cells to destroy cancer cells, has revolutionised treatment of some… Read More

#News #Trending News

MRI of the brain
#epilepsy #Mouse models #Neuroinflammation #Neuroscience

Neuroscientists discover new drug candidate for treating epilepsy

Neuroscientists have identified and developed a new drug candidate that has the potential to effectively treat temporal lobe epilepsy (TLE) by suppressing neuroinflammation.  Although symptomatic medications are available, one-third of TLE patients remain unresponsive to current treatment, so new drug targets are critically needed. Most of these… Read More

#News #Trending News

#Immunology #In vivo #Mouse models #T-Cells

Read the Top Five Benefits of a Cloud ELN

As experimental data becomes bigger and more complex, scientists are challenged to make discoveries faster, consistently document and analyse their work, and easily collaborate across an organisation and with external partners. Electronic lab notebooks (ELN) provide access to all collaborators 24/7, wherever they are and whether they are employees or… Read More

#Intelligence #Resources